← FDA Drug Approvals (Drugs@FDA)

VIEKIRA XR

NDA · New Drug Application · Sponsor: ABBVIE · Approved 2016-07-22

Drug application

FDA Application #

NDA208624

Application type

New Drug Application

Brand name

VIEKIRA XR

Generic name

Dasabuvir Sodium

Active ingredients

DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Discontinued

Sponsor

ABBVIE

First approval

2016-07-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown